Crown Prince donates SR1 billion to support housing for eligible families    Saudi, Iranian foreign ministers discuss Oman-mediated talks with US    Prince Sultan University launches first bachelor's program in language and media    Al-Falih: Eastern Province hosts 700 investment opportunities worth SR330 billion    India demolishes houses of 10 alleged militants days after deadly Kashmir attack    Yemen's Houthis claim dozens killed in US strike on prison holding African migrants    Putin announces three-day Russian ceasefire in Ukraine from 8 May    Suspect charged after Vancouver car ramming leaves 11 dead    Rock & Roll Hall of Fame picks Outkast but not Oasis    Makkah police arrest Yemeni and Egyptian suspects of fake Hajj campaign    stc reports strong first-quarter 2025 results with 11% rise in net profit    Saudi Awwal Bank records SR2.1 billion net profit after zakat and income tax for 1Q25    Virgin Atlantic celebrates one month of nonstop service between London and Riyadh    Al Ahli cruise past Buriram into AFC Champions League Elite semi-finals    Duran leads Al Nassr past Yokohama Marinos into AFC Champions League Elite semi-finals    Saudi orchestra to perform at Sydney Opera House in May    Al Hilal thrash Gwangju to reach AFC Champions League Elite semi-finals    Saudi Theater Commission launches its Work and Learn Project in UK    The season has begun — and one comment shook us all    Average life expectancy in Saudi Arabia rises to78.8 years    Pakistani star's Bollywood return excites fans and riles far right    Veteran Bollywood actor Manoj Kumar dies at 87    Bollywood actress vindicated over boyfriend's death after media hounding    Grand Mufti rules against posting prayers and preaching in mosques on social media    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



WHO approves Bharat Biotech's Covaxin for emergency use
Published in The Saudi Gazette on 03 - 11 - 2021

The World Health Organization (WHO) has granted emergency use listing to Covaxin, which is developed by Bharat Biotech, adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19.
The WHO Technical Advisory Group has determined that the Covaxin vaccine meets WHO standards for protection against COVID=19, that the benefit of the vaccine far outweighs risks and the vaccine can be used.
The vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks.
The WHO disclosed that available data on vaccination of pregnant women with the COVAXIN vaccine are insufficient to assess vaccine safety or efficacy in pregnancy, adding that Covaxin was found to have 78% efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements.
The 'made-in-India' vaccine is finally recognized by WHO and Indians who have received the shot need not self-quarantine or face restrictions when travelling abroad.
Covaxin has been cleared for use in all age groups (18+) over two doses spaced four weeks apart. However, no recommendation has been made for use on children, and available data for use on pregnant women is insufficient to assess safety or efficacy, WHO said.
Bharat Biotech said grant of the EUL was "a very significant step towards ensuring global access to India's widely administered, safe and efficacious (vaccine)".
"As an organization we have focused on maintaining stringent quality and safety standards that meet rigorous assessment and scientific standards established by WHO... EUL authorization for Covaxin will enable us to contribute to accelerating the equitable access of COVID-19 vaccines..." Dr. Krishna Ella, Bharat Biotech chairman and managing director, said.
The EUL comes after a lengthy and rigorous review period — Bharat Biotech provided the first batch of data in July — that involves assurances about the vaccine's safety, efficacy and stability, as well as checks of production facilities.
The delay left millions in limbo; in particular it was a huge problem for Indian students studying abroad in countries like Canada, the US, the UK, and Australia.
The WHO had said it "understands many people are waiting for Covaxin to be included in the COVID-19 Emergency Use Listing" but had also stressed "we cannot cut corners before recommending a product for emergency use... we must evaluate thoroughly to make it is safe and effective".
The WHO also underlined its trust of the Indian vaccine industry, and in its defense, referred to the 30 days it took for an EUL for Serum Institute's Covishield (the AstraZeneca-Oxford University shot).
"... this is not about moving quicker with one or another vaccine. We really trust the Indian industry."
The approval is also likely to clear the way for India to commit vaccine supplies to COVAX — the global vaccine-sharing effort co-led by the WHO which aims to provide vaccines to poorer countries.
Last month news agency Reuters reported the government was delaying a deal on that point while the WHO deliberated on approval for Coaxin.
Apart from Covishield and Covaxin, the WHO has so far approved vaccines produced by American pharma giants Pfizer, Johnson & Johnson and Moderna, and China's Sinopharm. — Agencies


Clic here to read the story from its source.